Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-9,561
Closed -$359K 881
2022
Q3
$359K Sell
9,561
-5,796
-38% -$230K 0.01% 633
2022
Q2
$554K Sell
15,357
-180
-1% -$7.45K 0.01% 575
2022
Q1
$761K Buy
15,537
+21
+0.1% +$1.06K 0.01% 539
2021
Q4
$743K Buy
15,516
+89
+0.6% +$4.21K 0.01% 508
2021
Q3
$677K Buy
15,427
+676
+5% +$28.6K 0.01% 502
2021
Q2
$647K Buy
+14,751
New +$693K 0.01% 470

Other funds holding SNV

Colony Group's SNV Position: Q4 2022 in Review

Colony Group sold out of Synovus (SNV) in Q4 2022, closing a stake of 9,561 shares — an estimated $359K sold.

Colony Group first reported a position in SNV in Q2 2021 and held it in 6 quarters. The position peaked at $761K in Q1 2022. 419 funds tracked by Wall St. Rank hold SNV as of Q4 2022.

  • Colony Group reported no remaining Synovus position as of Q4 2022 after selling out during the quarter.
  • Colony Group sold 9,561 Synovus shares in Q4 2022, an estimated $359K.
  • Colony Group first reported a position in Synovus in Q2 2021 and held it in 6 quarters.
  • Colony Group's Synovus position peaked at $761K in Q1 2022.
  • 419 funds tracked by Wall St. Rank held Synovus as of Q4 2022.

Based on Colony Group's 13F filing for Q4 2022, filed 14 Feb 2023.